Physician profile
Sunil K Gupta
NPI 1093886657
$1,621.19
in general payments reported to CMS, 2019-2025
21 companies · $24.15 in 2025
The $24.15 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,018 · 2020: $283 · 2021: $201 · 2022: $79.20 · 2023: $16.18 · 2025: $24.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $293.14 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $227.17 | 2019-2022 | |
| Novo Nordisk INC | $215.05 | 2019-2022 | |
| Astellas Pharma US INC | $154.47 | 2019 | |
| Sanofi-Aventis U.S. LLC | $111.94 | 2019 | |
| Pfizer INC. | $77.72 | 2020-2025 | |
| Lilly USA, LLC | $77.10 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $67.18 | 2019-2021 | |
| Abbvie INC. | $63.78 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $56.06 | 2019-2022 | |
| Amarin Pharma, INC. | $43.39 | 2019-2020 | |
| Amgen INC. | $42.57 | 2019 | |
| Merck Sharp & Dohme LLC | $37.12 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $26.50 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.11 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $22.66 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.63 | 2022 | |
| Abbott Laboratories | $19.65 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.77 | 2019 | |
| Eisai INC. | $13.50 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.